Patricia McCoon

2.2k total citations
33 papers, 982 citations indexed

About

Patricia McCoon is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Patricia McCoon has authored 33 papers receiving a total of 982 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 14 papers in Molecular Biology and 8 papers in Immunology. Recurrent topics in Patricia McCoon's work include Cancer Immunotherapy and Biomarkers (7 papers), Lung Cancer Treatments and Mutations (6 papers) and Cytokine Signaling Pathways and Interactions (6 papers). Patricia McCoon is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), Lung Cancer Treatments and Mutations (6 papers) and Cytokine Signaling Pathways and Interactions (6 papers). Patricia McCoon collaborates with scholars based in United States, Japan and France. Patricia McCoon's co-authors include Douglas A. Harrison, Michael Gilman, Richard Binari, Norbert Perrimon, Lourdes Pablo, Weifeng Tang, Elizabeth R. Plimack, Gregory A. Curt, Patricia LoRusso and Sabine Eckhardt and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Patricia McCoon

31 papers receiving 959 citations

Peers

Countries citing papers authored by Patricia McCoon

Since Specialization

Citations

This map shows the geographic impact of Patricia McCoon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patricia McCoon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patricia McCoon more than expected).

Fields of papers citing papers by Patricia McCoon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patricia McCoon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patricia McCoon. The network helps show where Patricia McCoon may publish in the future.

Co-authorship network of co-authors of Patricia McCoon

This figure shows the co-authorship network connecting the top 25 collaborators of Patricia McCoon. A scholar is included among the top collaborators of Patricia McCoon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patricia McCoon. Patricia McCoon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Mutational Landscape of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma and Association with Immune Checkpoint Inhibitor Outcomes 2025 ·Clinical Cancer Research ·Patricia McCoon, Ying Wang, Zhongwu Lai, Qu Zhang, (unknown), Sophie Wildsmith, Nassim Morsli, Rajiv Raja, Nicholas Holoweckyj, Jill Walker, Melissa de los Reyes, Ricard Mesı́a, Lisa Licitra, Robert L. Ferris, Jérôme Fayette, Dan P. Zandberg, Lillian L. Siu, Robert I. Haddad	1
2	Analysis of clinically actionable alterations in baseline tumor versus plasma samples in participants of the TOPAZ-1 study of durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer. 2025 ·Journal of Clinical Oncology ·Do‐Youn Oh, Shukui Qin, Lorenzo Antonuzzo, David Tougeron, Choong‐kun Lee, Benjamin Tan, Masafumi Ikeda, Julie Wang, Hung‐Ying Lin, Young S. Lee, Patricia McCoon, Juan W. Valle	0
3	T cell receptor and immune gene expression pharmacodynamics for durvalumab monotherapy and in combination with tremelimumab or bevacizumab in unresectable hepatocellular carcinoma (uHCC). 2024 ·Journal of Clinical Oncology ·Robin Kate Kelley, Young S. Lee, James R. W. Conway, John F. Kurland, Alejandra Negro, Patricia McCoon	1
4	Exposure-Response Analyses of Tremelimumab Monotherapy or in Combination with Durvalumab in Patients with Unresectable Hepatocellular Carcinoma 2022 ·Clinical Cancer Research ·Xuyang Song, Robin Kate Kelley, Anis A. Khan, Nathan Standifer, Diansong Zhou, (unknown), Rajesh Krishna, (unknown), Kun Wang, Patricia McCoon, Alejandra Negro, Philip He, Megan Gibbs, John F. Kurland, Ghassan K. Abou‐Alfa	21
5	269 Tumoral and peripheral landscape of Viral- versus Carcinogen-Driven Head and Neck Cancer 2020 ·SHILAP Revista de lepidopterología ·Tze Heng Tan, Sriram Sridhar, Helen K. Angell, (unknown), Amelia Raymond, Sophie E. Willis, Dimitris Polychronopoulos, Alejandro Yovine, Nassim Morsli, Patricia McCoon, Carl Barrett, Maria Libera Ascierto	1
6	Phase 1b/2 Study (SCORES) assessing safety, tolerability, and preliminary anti-tumor activity of durvalumab plus AZD9150 or AZD5069 in patients with advanced solid malignancies and squamous cell carcinoma of the head and neck (SCCHN) 2017 ·Annals of Oncology ·Ezra E.W. Cohen, David S. Hong, (unknown), William N. William, D. Schrijvers, (unknown), Martin Scott, Paul D. Lyne, Ganesh Mugundu, Patricia McCoon, Carl Cook, Minal Mehta, Ulrich Keilholz	19
7	Abstract 3684: Inhibition of STAT3 by antisense oligonucleotide treatment decreases the immune suppressive tumor microenvironment in syngeneic and GEM tumor models 2017 ·Cancer Research ·Rich Woessner, Vasu R. Sah, Patricia McCoon, Shaun Grosskurth, Nanhua Deng, Rachel DuPont, Deborah Lawson, Lourdes Pablo, Corinne Reimer, Marco A. De Velasco, Hirotsugu Uemura, Juliana Candido, Paul D. Lyne	1
8	A phase 1b study (SCORES) assessing safety, tolerability, pharmacokinetics, and preliminary anti-tumor activity of durvalumab combined with AZD9150 or AZD5069 in patients with advanced solid malignancies and SCCHN 2016 ·Annals of Oncology ·David S. Hong, Gerald S. Falchook, Carl Cook, Wael A. Harb, Paul D. Lyne, Patricia McCoon, Minal Mehta, Pat Mitchell, Ganesh Mugundu, Martin Scott, (unknown)	7
9	A phase I, open-label, multi-center study of the JAK2 inhibitor AZD1480 in patients with myelofibrosis 2014 ·Leukemia Research ·Srđan Verstovšek, Ronald Hoffman, John Mascarenhas, Jean‐Charles Soria, Ratislav Bahleda, Patricia McCoon, Weifeng Tang, Jörge E. Cortes, Hagop M. Kantarjian, Vincent Ribrag	25
10	217 Results of a phase I, open-label, multicentre study to assess the safety, tolerability, pharmacokinetics and preliminary anti-tumour activity of AZD9150 in patients with advanced/metastatic hepatocellular carcinoma 2014 ·European Journal of Cancer ·Yoon‐Koo Kang, Baek‐Yeol Ryoo, (unknown), K.H. Lee, (unknown), (unknown), Masafumi Ikeda, Takuji Okusaka, Seijin Nadano, (unknown), (unknown), Clarence Yen, Patricia McCoon, (unknown), (unknown), Renee M. Dupont, Paul D. Lyne	4
11	A Human Monoclonal Anti-ANG2 Antibody Leads to Broad Antitumor Activity in Combination with VEGF Inhibitors and Chemotherapy Agents in Preclinical Models 2010 ·Molecular Cancer Therapeutics ·Jeffrey L. Brown, Zhe Cao, Maria Pinzon-Ortiz, Jane Kendrew, Corinne Reimer, Shenghua Wen, (unknown), Mohammad Tabrizi, (unknown), (unknown), Lourdes Pablo, Patricia McCoon, Vahe Bedian, David C. Blakey	113
12	Epitope-Dependent Effect of Anti-Murine TIM-1 Monoclonal Antibodies on T Cell Activity and Lung Immune Responses 2007 ·The Journal of Immunology ·Irene Sizing, Véronique Bailly, Patricia McCoon, (unknown), Sambasiva P. Rao, Lourdes Pablo, Rachel Rennard, (unknown), Zhifang Li, Mohammad Zafari, Max Dobles, (unknown), Steven D. Miklasz, Gerard R. Majeau, Kevin Godbout, Martin Scott, Paul D. Rennert	66
13	T Cell, Ig Domain, Mucin Domain-2 Gene-Deficient Mice Reveal a Novel Mechanism for the Regulation of Th2 Immune Responses and Airway Inflammation 2006 ·The Journal of Immunology ·Paul D. Rennert, Takaharu Ichimura, Irene Sizing, Véronique Bailly, Zhifang Li, Rachel Rennard, Patricia McCoon, Lourdes Pablo, Steven D. Miklasz, (unknown), Joseph V. Bonventre	64
14	A Drosophila Derailed homolog, Doughnut, expressed in invaginating cells during embryogenesis 1999 ·Gene ·Smita Savant‐Bhonsale, Matthew B. Friese, Patricia McCoon, Denise J. Montell	13
15	Drosophila unpaired encodes a secreted protein that activates the JAK signaling pathway 1998 ·Genes & Development ·Douglas A. Harrison, Patricia McCoon, Richard Binari, Michael Gilman, Norbert Perrimon	296
16	Sea Urchin FGFR Muscle-Specific Expression: Posttranscriptional Regulation in Embryos and Adults 1998 ·Developmental Biology ·Patricia McCoon, (unknown), Robert C. Angerer, Lynne M. Angerer	15
17	SpFGFR, a New Member of the Fibroblast Growth Factor Receptor Family, Is Developmentally Regulated during Early Sea Urchin Development 1996 ·Journal of Biological Chemistry ·Patricia McCoon, Robert C. Angerer, Lynne M. Angerer	24
18	Insertional gene synthesis, a novel method of assembling consecutive DNA sequences within specific sites in plasmids. Construction of the HIV-1tatgene 1990 ·Nucleic Acids Research ·Richard B. Ciccarelli, (unknown), Patricia McCoon, Donald L. Holzschu	6
19	Monoclonal Antibody to a 35 kD Epidermal Protein Induces Cell Detachment 1986 ·Journal of Investigative Dermatology ·(unknown), Alfred T. Lane, Patricia McCoon, Janet A. Fairley, Lowell A. Goldsmith	7
20	Decreased anchoring-fibril antigens (AF1 and AF2) in basal-cell carcinoma 1985 ·Archives of Dermatological Research ·A. Lane, Lowell A. Goldsmith, Patricia McCoon, Jan E. Muhlbauer	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact